Sidoti Upgrades Bio-Rad Labs (BIO) to Buy

Go back to Sidoti Upgrades Bio-Rad Labs (BIO) to Buy

Bio-Rad Laboratories Inc. (BIO) Tops Q4 EPS by 31c

February 26, 2013 4:21 PM EST

Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q4 EPS of $1.65, $0.31 better than the analyst estimate of $1.34. Revenue for the quarter came in at $573.8 million versus the consensus estimate of $558.68 million.

For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.... More